We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$251M
AUM Growth
-$19M
Cap. Flow
-$2.24M
Cap. Flow %
-0.89%
Top 10 Hldgs %
7.1%
Holding
477
New
43
Increased
256
Reduced
137
Closed
41

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$962K
2
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$944K
3
ENPH icon
Enphase Energy
ENPH
+$834K
4
DVN icon
Devon Energy
DVN
+$751K
5
IT icon
Gartner
IT
+$742K

Top Sells

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$785K
2
LHX icon
L3Harris
LHX
+$740K
3
A icon
Agilent Technologies
A
+$713K
4
CPRT icon
Copart
CPRT
+$688K
5
CQP icon
Cheniere Energy
CQP
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 18.83%
2 Real Estate 17.55%
3 Materials 12.77%
4 Financials 9.88%
5 Energy 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYNB
351
Kyntra Bio
KYNB
$27.4M
$152K 0.06%
466
+3
+0.6% +$966
NTLA icon
352
Intellia Therapeutics
NTLA
$1.51B
$152K 0.06%
2,720
+26
+1% +$1.61K
ALXO icon
353
ALX Oncology
ALXO
$262M
$151K 0.06%
15,756
+115
+0.7% +$1.34K
DNLI icon
354
Denali Therapeutics
DNLI
$3.79B
$150K 0.06%
4,875
+36
+0.7% +$1.17K
SWTX
355
DELISTED
SpringWorks Therapeutics
SWTX
$147K 0.06%
5,151
+40
+0.8% +$1.15K
QURE icon
356
uniQure
QURE
$2.75B
$146K 0.06%
7,802
+52
+0.7% +$1.09K
NSLR
357
Neostellar Capital Corp
NSLR
$258M
$146K 0.06%
+37,817
New +$231K
RNAM
358
DELISTED
Avidity Biosciences
RNAM
$145K 0.06%
8,852
+71
+0.8% +$1.36K
KROS icon
359
Keros Therapeutics
KROS
$197M
$144K 0.06%
3,825
+32
+0.8% +$1.11K
KRYS icon
360
Krystal Biotech
KRYS
$10.7B
$144K 0.06%
2,071
+16
+0.8% +$1.16K
MORF
361
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$143K 0.06%
5,068
+41
+0.8% +$1.14K
PCVX icon
362
Vaxcyte
PCVX
$7.65B
$142K 0.06%
5,910
+45
+0.8% +$1.14K
NRIX icon
363
Nurix Therapeutics
NRIX
$2.45B
$141K 0.06%
10,813
+78
+0.7% +$1.24K
RGNX icon
364
Regenxbio
RGNX
$616M
$139K 0.06%
5,248
+39
+0.7% +$1.16K
MRTX
365
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$139K 0.06%
1,989
+14
+0.7% +$1.04K
IDYA icon
366
IDEAYA Biosciences
IDYA
$3.43B
$137K 0.05%
9,156
+68
+0.7% +$883
CLDX icon
367
Celldex Therapeutics
CLDX
$2.94B
$136K 0.05%
4,847
+31
+0.6% +$950
XNCR icon
368
Xencor
XNCR
$1.45B
$136K 0.05%
5,220
+35
+0.7% +$1K
EQRX
369
DELISTED
EQRx, Inc. Common Stock
EQRX
$136K 0.05%
27,494
+205
+0.8% +$1.03K
BTAI icon
370
BioXcel Therapeutics
BTAI
$24.8M
$134K 0.05%
710
+5
+0.7% +$1.16K
RWAY icon
371
Runway Growth Finance
RWAY
$235M
$134K 0.05%
+11,819
New +$147K
RCUS icon
372
Arcus Biosciences
RCUS
$3.33B
$133K 0.05%
5,068
+39
+0.8% +$1.03K
XENE icon
373
Xenon Pharmaceuticals
XENE
$6.1B
$133K 0.05%
3,673
+30
+0.8% +$1.08K
ACET icon
374
Adicet Bio
ACET
$77.6M
$132K 0.05%
578
+4
+0.7% +$1.01K
DAWN
375
DELISTED
Day One Biopharmaceuticals
DAWN
$132K 0.05%
6,601
+50
+0.8% +$1.06K
13 14
15
16 17

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2022 Portfolio in Review

As of Q3 2022, Virtus ETF Advisers held 477 positions worth $251M, down 7% from $270M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Virtus ETF Advisers's Q3 2022 filing shows 43 new, 256 increased, 137 reduced and 41 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K. The largest sale was Moderna, an estimated $785K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Real Estate and Materials.

  • Virtus ETF Advisers's largest Q3 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K.
  • Virtus ETF Advisers added most to The Mosaic Company in Q3 2022, an estimated $962K increase.
  • Virtus ETF Advisers's biggest Q3 2022 reduction was Moderna, cutting an estimated $785K.
  • Virtus ETF Advisers fully exited L3Harris in Q3 2022, selling an estimated $740K.
  • Virtus ETF Advisers's ten largest holdings make up 7.1% of its $251M portfolio in Q3 2022.
  • Virtus ETF Advisers opened 43 new positions and closed 41 in Q3 2022.
  • Virtus ETF Advisers's portfolio value fell 7% quarter-over-quarter to $251M.

Based on Virtus ETF Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.